Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Twigg

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Diabetic Medicine : a Journal of the British Diabetic Association|January 23, 2020
Young-onset type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complicationsT L Middleton, M I Constantino, L Molyneaux, et al.
Diabetes Research and Clinical Practice|March 4, 2014
Age of diabetes diagnosis and diabetes duration associate with glycated haemoglobinA Hsieh, P X Ong, L Molyneaux, et al.
Endocrinology|April 24, 2001
Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitusS M Twigg, M M Chen, A H Joly, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2015
Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyK H Williams, D R Sullivan, A S Veillard, et al.
Diabetologia|July 3, 2007
Alterations in liver sinusoidal endothelium in a baboon model of type 1 diabetesH A Jamieson, V C Cogger, S M Twigg, et al.
Diabetes Research and Clinical Practice|April 4, 2015
Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesityK H Williams, A J Viera de Ribeiro, E Prakoso, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Diabetic Medicine : a Journal of the British Diabetic Association|January 23, 2020
Young-onset type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complicationsT L Middleton, M I Constantino, L Molyneaux, et al.
Diabetes Research and Clinical Practice|March 4, 2014
Age of diabetes diagnosis and diabetes duration associate with glycated haemoglobinA Hsieh, P X Ong, L Molyneaux, et al.
Endocrinology|April 24, 2001
Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitusS M Twigg, M M Chen, A H Joly, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2015
Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyK H Williams, D R Sullivan, A S Veillard, et al.
Diabetologia|July 3, 2007
Alterations in liver sinusoidal endothelium in a baboon model of type 1 diabetesH A Jamieson, V C Cogger, S M Twigg, et al.
Diabetes Research and Clinical Practice|April 4, 2015
Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesityK H Williams, A J Viera de Ribeiro, E Prakoso, et al.
Pageof 4